AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
Log in

NASDAQ:LMATLeMaitre Vascular News Headlines

$25.73
-0.08 (-0.31 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$25.54
Now: $25.73
$26.05
50-Day Range
$23.68
MA: $25.87
$28.22
52-Week Range
$18.76
Now: $25.73
$38.64
Volume52,180 shs
Average Volume140,398 shs
Market Capitalization$519.28 million
P/E Ratio29.57
Dividend Yield1.47%
Beta1.37

Headlines

LeMaitre Vascular (NASDAQ LMAT) News Headlines

Source:
DateHeadline
LeMaitre Vascular Inc (NASDAQ:LMAT) Receives Average Rating of "Hold" from AnalystsLeMaitre Vascular Inc (NASDAQ:LMAT) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - June 28 at 1:26 AM
Zacks: Analysts Anticipate LeMaitre Vascular Inc (NASDAQ:LMAT) Will Announce Quarterly Sales of $15.58 MillionZacks: Analysts Anticipate LeMaitre Vascular Inc (NASDAQ:LMAT) Will Announce Quarterly Sales of $15.58 Million
www.americanbankingnews.com - June 26 at 5:51 AM
LeMaitre Vascular: Looking FairLeMaitre Vascular: Looking Fair
seekingalpha.com - June 25 at 11:02 PM
LaMaitre Vascular buys vascular graft seller Artegraft for $90MLaMaitre Vascular buys vascular graft seller Artegraft for $90M
seekingalpha.com - June 24 at 3:01 PM
LeMaitre Vascular Inc (NASDAQ:LMAT) Expected to Announce Earnings of -$0.05 Per ShareLeMaitre Vascular Inc (NASDAQ:LMAT) Expected to Announce Earnings of -$0.05 Per Share
www.americanbankingnews.com - June 24 at 1:46 AM
LeMaitre Vascular (NASDAQ:LMAT) Rating Reiterated by Canaccord GenuityLeMaitre Vascular (NASDAQ:LMAT) Rating Reiterated by Canaccord Genuity
www.americanbankingnews.com - June 23 at 12:27 PM
LeMaitre Vascular Acquires ArtegraftLeMaitre Vascular Acquires Artegraft
finance.yahoo.com - June 22 at 6:04 PM
LeMaitre Vascular Inc (NASDAQ:LMAT) Short Interest UpdateLeMaitre Vascular Inc (NASDAQ:LMAT) Short Interest Update
www.americanbankingnews.com - June 18 at 8:40 PM
A Look Into LeMaitre Vasculars Price Over EarningsA Look Into LeMaitre Vascular's Price Over Earnings
finance.yahoo.com - June 9 at 6:07 PM
Admedus Changes Name to Anteris Technologies LtdAdmedus Changes Name to Anteris Technologies Ltd
finance.yahoo.com - June 1 at 8:48 AM
LeMaitre Vascular to Present at the Jefferies Virtual Healthcare ConferenceLeMaitre Vascular to Present at the Jefferies Virtual Healthcare Conference
www.benzinga.com - May 28 at 6:11 PM
BRIEF-Lemaitre Vascular Files For Mixed Shelf Of Upto $200 MlnBRIEF-Lemaitre Vascular Files For Mixed Shelf Of Upto $200 Mln
www.reuters.com - May 20 at 9:25 PM
LeMaitre VascularLeMaitre Vascular
www.fool.com - May 14 at 11:51 PM
LeMaitre Vascular to Present at the UBS Virtual Global Healthcare ConferenceLeMaitre Vascular to Present at the UBS Virtual Global Healthcare Conference
finance.yahoo.com - May 12 at 3:49 PM
LeMaitre Vascular (LMAT) Q1 2020 Earnings Call TranscriptLeMaitre Vascular (LMAT) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 1 at 10:52 PM
Edited Transcript of LMAT earnings conference call or presentation 30-Apr-20 9:00pm GMTEdited Transcript of LMAT earnings conference call or presentation 30-Apr-20 9:00pm GMT
finance.yahoo.com - May 1 at 8:19 AM
LeMaitre Vascular (LMAT) Meets Q1 Earnings EstimatesLeMaitre Vascular (LMAT) Meets Q1 Earnings Estimates
www.nasdaq.com - April 30 at 10:13 PM
LeMaitre Vascular EPS in-line, beats on revenueLeMaitre Vascular EPS in-line, beats on revenue
seekingalpha.com - April 30 at 5:13 PM
LeMaitre Vascular Announces Q1 2020 Financial ResultsLeMaitre Vascular Announces Q1 2020 Financial Results
finance.yahoo.com - April 30 at 5:13 PM
Earnings Preview: LeMaitre Vascular (LMAT) Q1 Earnings Expected to DeclineEarnings Preview: LeMaitre Vascular (LMAT) Q1 Earnings Expected to Decline
finance.yahoo.com - April 23 at 2:40 PM
BRIEF-Lemaitre Vascular Committed To Plan For Reducing Expenses, Including Reduction In Force Of About 13% Of WorkforceBRIEF-Lemaitre Vascular Committed To Plan For Reducing Expenses, Including Reduction In Force Of About 13% Of Workforce
www.reuters.com - April 17 at 8:01 PM
LeMaitre Vascular Withdraws Prior Annual Guidance for 2020 And Announces Preliminary Q1 2020 Financial ResultsLeMaitre Vascular Withdraws Prior Annual Guidance for 2020 And Announces Preliminary Q1 2020 Financial Results
finance.yahoo.com - April 13 at 9:16 PM
LeMaitre Vascular Withdraws Prior Annual Guidance for 2020 And Announces Preliminary Q1 2020 Financial ResultsLeMaitre Vascular Withdraws Prior Annual Guidance for 2020 And Announces Preliminary Q1 2020 Financial Results
finance.yahoo.com - April 13 at 9:16 PM
Should You Worry About LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) CEO Salary Level?Should You Worry About LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) CEO Salary Level?
finance.yahoo.com - April 9 at 1:40 PM
LeMaitre Vascular: Beware Valuation ResetLeMaitre Vascular: Beware Valuation Reset
seekingalpha.com - March 27 at 2:40 PM
Are Investors Undervaluing LeMaitre Vascular, Inc. (NASDAQ:LMAT) By 37%?Are Investors Undervaluing LeMaitre Vascular, Inc. (NASDAQ:LMAT) By 37%?
finance.yahoo.com - March 17 at 2:51 PM
LeMaitre Vascular to Present at Upcoming Investor ConferencesLeMaitre Vascular to Present at Upcoming Investor Conferences
finance.yahoo.com - March 4 at 1:39 PM
Is It Smart To Buy LeMaitre Vascular, Inc. (NASDAQ:LMAT) Before It Goes Ex-Dividend?Is It Smart To Buy LeMaitre Vascular, Inc. (NASDAQ:LMAT) Before It Goes Ex-Dividend?
finance.yahoo.com - February 26 at 7:18 AM
Walgreens U.S. Retail Pharmacy Rises Amid Reimbursement WoesWalgreens U.S. Retail Pharmacy Rises Amid Reimbursement Woes
finance.yahoo.com - February 13 at 1:57 PM
Edited Transcript of LMAT earnings conference call or presentation 6-Feb-20 10:00pm GMTEdited Transcript of LMAT earnings conference call or presentation 6-Feb-20 10:00pm GMT
finance.yahoo.com - February 11 at 6:51 PM
LeMaitre Vascular, Inc. Annual Results Just Came Out: Heres What Analysts Are Forecasting For Next YearLeMaitre Vascular, Inc. Annual Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
finance.yahoo.com - February 9 at 2:33 PM
LeMaitre Vascular, Inc. Annual Results Just Came Out: Here's What Analysts Are Forecasting For Next YearLeMaitre Vascular, Inc. Annual Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
finance.yahoo.com - February 9 at 9:29 AM
LeMaitre Vascular, Inc. (LMAT) CEO George LeMaitre on Q4 2019 Results - Earnings Call TranscriptLeMaitre Vascular, Inc. (LMAT) CEO George LeMaitre on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - February 7 at 8:48 AM
LeMaitre Vascular (LMAT) Q4 Earnings Match EstimatesLeMaitre Vascular (LMAT) Q4 Earnings Match Estimates
finance.yahoo.com - February 6 at 11:34 PM
LeMaitre Vascular EPS in-line, misses on revenueLeMaitre Vascular EPS in-line, misses on revenue
seekingalpha.com - February 6 at 6:33 PM
LeMaitre Vascular declares $0.095 dividendLeMaitre Vascular declares $0.095 dividend
seekingalpha.com - February 6 at 6:33 PM
LeMaitre Vascular Announces Q4 2019 Financial ResultsLeMaitre Vascular Announces Q4 2019 Financial Results
finance.yahoo.com - February 6 at 6:33 PM
LeMaitre Vascular Q4 Earnings PreviewLeMaitre Vascular Q4 Earnings Preview
seekingalpha.com - February 5 at 6:58 PM
LeMaitre Vascular Will Announce Fourth Quarter 2019 Earnings Results on February 6, 2020LeMaitre Vascular Will Announce Fourth Quarter 2019 Earnings Results on February 6, 2020
finance.yahoo.com - January 29 at 6:27 PM
Shareholders Are Raving About How The LeMaitre Vascular (NASDAQ:LMAT) Share Price Increased 368%Shareholders Are Raving About How The LeMaitre Vascular (NASDAQ:LMAT) Share Price Increased 368%
finance.yahoo.com - January 22 at 1:26 PM
Top Picks 2020- LeMaitre Vascular LMATTop Picks 2020- LeMaitre Vascular LMAT
finance.yahoo.com - January 10 at 9:17 PM
LeMaitre Vascular to Present at the Needham Growth Conference on Wednesday, January 15, 2020LeMaitre Vascular to Present at the Needham Growth Conference on Wednesday, January 15, 2020
finance.yahoo.com - January 3 at 3:25 PM
Does LeMaitre Vascular, Inc. (NASDAQ:LMAT) Have A Volatile Share Price?Does LeMaitre Vascular, Inc. (NASDAQ:LMAT) Have A Volatile Share Price?
finance.yahoo.com - January 2 at 4:49 PM
Why LeMaitre Vascular, Inc. (NASDAQ:LMAT) Looks Like A Quality CompanyWhy LeMaitre Vascular, Inc. (NASDAQ:LMAT) Looks Like A Quality Company
finance.yahoo.com - December 9 at 1:54 PM
Commit To Purchase LeMaitre Vascular At $30, Earn 10.8% Annualized Using OptionsCommit To Purchase LeMaitre Vascular At $30, Earn 10.8% Annualized Using Options
www.nasdaq.com - December 4 at 1:39 PM
Shareholders Are Loving LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) 1.0% YieldShareholders Are Loving LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) 1.0% Yield
finance.yahoo.com - November 19 at 9:12 AM
EYE vs. LMAT: Which Stock Is the Better Value Option?EYE vs. LMAT: Which Stock Is the Better Value Option?
finance.yahoo.com - November 14 at 1:38 PM
Did Hedge Funds Drop The Ball On LeMaitre Vascular Inc (LMAT) ?Did Hedge Funds Drop The Ball On LeMaitre Vascular Inc (LMAT) ?
finance.yahoo.com - October 30 at 11:48 PM
Dont Ignore The Fact That This Insider Just Sold Some Shares In LeMaitre Vascular, Inc. (NASDAQ:LMAT)Don't Ignore The Fact That This Insider Just Sold Some Shares In LeMaitre Vascular, Inc. (NASDAQ:LMAT)
finance.yahoo.com - October 30 at 1:47 PM
Don't Ignore The Fact That This Insider Just Sold Some Shares In LeMaitre Vascular, Inc. (NASDAQ:LMAT)Don't Ignore The Fact That This Insider Just Sold Some Shares In LeMaitre Vascular, Inc. (NASDAQ:LMAT)
finance.yahoo.com - October 30 at 1:47 PM
This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.